News
13h
Barchart on MSNPfizer Earnings Preview: What to ExpectWith a market cap of $145.7 billion, Pfizer Inc. (PFE) is a global, research-driven biopharmaceutical company, specializing ...
One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...
16h
Zacks Investment Research on MSNJNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified ...
A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...
Pfizer Inc. closed 18.77% short of its 52-week high of $31.54, which the company achieved on July 30th.
The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
6don MSN
At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...
Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...
1d
Zacks.com on MSNPfizer (PFE) Ascends While Market Falls: Some Facts to NoteIn the latest close session, Pfizer (PFE) was up +1.51% at $25.62. The stock's performance was ahead of the S&P 500's daily loss of 0.07%. Elsewhere, the Dow saw a downswing of 0.37%, while the ...
The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the ...
The U.S. House Judiciary Committee on Monday subpoenaed a former Pfizer executive after he declined to voluntarily comply ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results